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a b s t r a c t 
Numerous studies have investigated grey matter (GM) volume changes in diverse patient groups. Reports of 
disorder-related GM reductions are common in such work, but many studies also report evidence for GM vol- 
ume increases in patients. It is unclear whether these GM increases and decreases are independent or related in 
some way. Here, we address this question using a novel meta-analytic network mapping approach. We used a 
coordinate-based meta-analysis of 64 voxel-based morphometry studies of psychiatric disorders to calculate the 
probability of finding a GM increase or decrease in one region given an observed change in the opposite direction 
in another region. Estimating this co-occurrence probability for every pair of brain regions allowed us to build a 
network of concurrent GM changes of opposing polarity. Our analysis revealed that disorder-related GM increases 
and decreases are not independent; instead, a GM change in one area is often statistically related to a change of 
opposite polarity in other areas, highlighting distributed yet coordinated changes in GM volume as a function of 
brain pathology. Most regions showing GM changes linked to an opposite change in a distal area were located 
in salience, executive-control and default mode networks, as well as the thalamus and basal ganglia. Moreover, 
pairs of regions showing coupled changes of opposite polarity were more likely to belong to different canonical 
networks than to the same one. Our results suggest that regional GM alterations in psychiatric disorders are often 








































A large body of neuroimaging studies has investigated how diverse
iseases are associated with altered brain structure, most commonly
uantified through measures of regional grey matter (GM) volume. The
ast majority of studies have focused on mapping localized changes
sing mass univariate approaches such as voxel-based morphometry
 Ashburner and Friston, 2000 ), but analyses of covariations in regional
olume changes are also thought to reveal pathological mechanisms
nd to reflect the distributed and interconnected nature of the brain
 Evans, 2013 ). By far, most work in this area has focused on under-
tanding GM volume reductions in clinical disease. Not only have several
eta-analyses of different diseases shown that such reductions are com-
on ( Bora et al., 2011 , 2010 ; Bora et al., 2012a, 2012b ; Cauda et al.,
014 ; Du et al., 2012 ; Fornito et al., 2009 ; Foster et al., 2015 ; Fusar-
oli et al., 2011 ; Hallahan et al., 2011 ; Li et al., 2014 , 2018 ; Lin et al.,
016 ; Linkersdörfer et al., 2012 ; Stoodley, 2014 ; Wise et al., 2017 ;∗ Corresponding author. 
E-mail address: tommaso.costa@unito.it (T. Costa). 
(  
ttps://doi.org/10.1016/j.neuroimage.2020.117220 
eceived 2 June 2020; Received in revised form 24 July 2020; Accepted 28 July 202
vailable online 8 August 2020 
053-8119/© 2020 The Author(s). Published by Elsevier Inc. This is an open access 
 http://creativecommons.org/licenses/by-nc-nd/4.0/ ) u et al., 2018 ), but many studies have suggested that anatomically
istributed yet coordinated GM reductions are tied to the underlying
onnectivity between regions ( Cauda et al., 2018a ; Crossley et al., 2014 ;
turria-Medina et al., 2014 ; Manuello et al., 2018 ; Raj et al., 2012 ;
eeley et al., 2009 ; Yau et al., 2018 ; Zeighami et al., 2015 ; Zheng et al.,
019 ; Zhou et al., 2012 ). In contrast, GM increases are less commonly
onsidered in neuroimaging meta-analyses ( Cauda et al., 2019 , 2018b ,
017 , 2011 ; Ding et al., 2019 ; Lu et al., 2019 ; Tatu et al., 2018 ), poten-
ially because they might be a rarer consequence of disease and because
hey can be difficult to explain in the context of pathology. Indeed, while
 morphometric decrease can be easily interpreted as a sign of neurode-
eneration or neurodevelopmental hyperpruning, the interpretation of
 disorder-related GM increase is less clear. 
Candidate mechanisms for increased GM include modifications to
euronal tissue, such as neurogenesis ( Eriksson et al., 1998 ), synapto-
enesis ( Sarrazin et al., 2019 ) or changes in somal size and density,
n addition to changes in glia ( Rocha et al., 1998 ) or neurovasculature
 Zatorre et al., 2012 ). There could be diverse causes of such modifica-0 
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c  ions, which may be related to inflammatory processes ( Poletti et al.,
019 ) that might, for instance, induce astrocytic hypertrophy ( Li et al.,
019 ), or to activity-driven volumetric increases similar to those ob-
erved during learning ( Zatorre et al., 2012 ). Medications may also an
ypertrophic effect ( Torres et al., 2013 ). Otherwise, a GM increase in
atients compared to controls could derive from a pathologic hypoprun-
ng that could characterize neurodevelopmental diseases such as autism
 Frith, 2004 ; Kim et al., 2017 ; Tang et al., 2014 ). More trivial rea-
ons, such as case-control differences in hydration, head motion, and
arious other metabolic and physical confounds may also play a role
 Weinberger and Radulescu, 2016 ). 
Some authors hypothesised that GM increases could emerge as a
ompensatory response to localised damage elsewhere. For instance,
anson and colleagues ( Janson et al., 1991 ) observed neuronal hyper-
rophy in regions connected to a mesencephalic lesion, which they
nterpreted as a compensation to the injury. Stevens and colleagues
 Stevens, 1992 ) proposed that hippocampal lesions might produce ax-
nal sprouting and synapse proliferation in deafferented regions, and
hat these changes should have a compensatory function if the rewiring
s adaptive. However, they could also lead to a further impairment if the
daptation is suboptimal. In major depression, cortical thickness stud-
es suggest that an early phase of the disease could be characterized
y an increased thickness in some regions, in which provisional com-
ensatory mechanisms take place to overcome the deficits induced by
he damage in others ( Li et al., 2019 ; Qiu et al., 2014 ). Indirect ev-
dence for the existence compensatory changes in GM volume comes
rom a meta-analysis ( Cauda et al., 2014 ) showing that, in people with
utism, a GM decrease in one area is associated with an increase of
olume and/or DTI-related measures of connectivity in the white mat-
er tracts connecting the affected area. Importantly, a structural covari-
nce study observed frequent associations between divergent cortical
hickness changes in subjects with schizophrenia ( Guo et al., 2016 ). In
unctional neuroimaging, several studies suggest the presence of com-
ensatory activations during both healthy ageing and in diverse diseases
eg. Dolcos et al., 2002 ; Tan et al., 2006 ; Crossley et al., 2016 ). For in-
tance, after traumatic brain injury, increased functional connectivity
f default mode network (DMN), salience network (SN) and executive
ontrol network (ECN) has been observed ( Hillary et al., 2014 ). These
ndings align with the view that the interconnected architecture of the
rain means that pathology is seldom defined to a single locus, and may
nduce distributed responses that are both adaptive and/or maladaptive
 Fornito et al., 2015 ). 
The eventual presence of compensatory mechanisms in brain dis-
rders might be of great relevance in clinical neuroscience, for instance
or the development of neurorehabilitative therapies. More in general, if
M decreases and increases were associated by some form of anatomical
ounterbalancing, to shed light on such phenomenon would be or cru-
ial importance for the understanding of the development of the disease.
lso, if volumetric increases were at least partly related to decreases, it
ould help to explain their presence in brain pathology. However, at
he best of our knowledge, only the aforementioned research by Guo
nd colleagues (2016) has directly addressed the hypothesis that GM
hanges in opposite direction can be associated. 
If compensatory changes in GM volume do occur in the dis-
ased brain, or if disorder-related GM increases and decreases are
ore broadly coordinated in some way, then we should expect that
hese changes should be statistically associated across different disor-
ers. To test this hypothesis, we extended a coordinate-based meta-
nalytic methodology developed by our group ( Cauda et al., 2018b ;
anuello et al., 2018 ; Tatu et al., 2018 ) to calculate the probability of
o-occurence between GM increases and decreases in VBM studies. This
robability quantifies the likelihood that a GM increase or decrease in
ne brain area co-occurs with a GM change of opposite polarity in an-
ther area. We adopted a transdiagnostic approach, considering all the
rain disorders that would show an association between GM decreases
nd increases, to identify disease-invariant co-alteration mechanisms ofrain pathology ( Buckholtz and Meyer-Lindenberg, 2012 ; Cauda et al.,
018b ). Thus, we aimed to obtain a network of GM co-alterations of
pposing polarity (COA-O) that identifies pairs of regions for which
here is a statistical dependence between these two opposite forms of
M change. Given prior work indicating that networks of co-alterations
i.e., GM changes of the same polarity) are related to normative connec-
ivity patterns ( Cauda et al., 2018b ; Raj and Powell, 2018 ; Yates, 2012 ),
e further hypothesised that the COA-O network would show a signif-
cant correlation with functional connectivity (FC) networks in healthy
ndividuals. 
. Material and methods 
.1. Data collection 
We adopted the Cochrane Collaboration definition of meta-analysis
 Green et al., 2008 ) and the “PRISMA statement ” international guide-
ines for the selection of studies ( Liberati et al., 2009 ; Moher et al.,
009 ). Coordinates of statistically significant GM changes were obtained
rom the BrainMap database ( http://brainmap.org/ ), which is a freely
vailable online database ( Fox et al., 2005 ; Fox and Lancaster, 2002 ;
aird et al., 2005 ; Vanasse et al., 2018 ) whose VBM section currently
ncludes 1002 papers, 3179 experiments for a total of 81,496 subject
nd 22,332 foci of alteration. 
Two queries were conducted on the VBM BrainMap section (Novem-
er 2019) to retrieve data on morphometric decreases and increases,
espectively: 
1) [Experiments Context is Disease] AND [Experiment Contrast is grey
Matter] AND [Experiments Observed Changes is Controls > Patients];
2) [Experiments Context is Disease] AND [Experiment Contrast is grey
Matter] AND [Experiments Observed Changes is Patients > Controls].
We obtained 1001 studies reporting GM decreases and 382 stud-
es reporting GM increases. All the selected experiments with a sam-
le size smaller than 8 participants were eliminated, in line with
carpazza et al. (2015) , who showed that VBM experiments with more
han 8 subjects should not be biased by an increased false positive rate.
hen we coded the experiments according to the ICD-10 classification
 World Health Organisation, 1992 ), to exclude the non-neurological and
on-psychiatric diseases from the database. In order to quantify the co-
ccurrence of decreases and increases, we further selected only those
ouples of experiments (i.e. set of foci resulting by a given statistical
omparison) that reported opposing changes between the same groups
f patients and healthy controls. Such selection resulted in 170 exper-
ments (85 decreases exp., 85 increases exp.), further reduced to 128
fter the exclusion of neurological diseases (see Results), for a total of
910 subjects. See Table 1 and 2 for a list of the experiments and disor-
ers considered. 
To maximize the sample size, the experiments belonging to the same
aper were not excluded from the database. However, this might bias
he results as they are not independent observations. Specifically, 4 ex-
eriments included in the database were carried out on a subgroup of
nother one, and 1 was a retest in a longitudinal study. A secondary
OA-O database has been made excluding those 5 experiments (see Sup-
lementary Table S1) to verify how much they impacted on the results.
To obtain two control datasets of common change (i.e., datasets
n which only GM decreases or only GM increases were reported),
e selected from the total pool of 1382 experiments, those consider-
ng the 9 diagnoses we focus on (schizophrenia, autism, bipolar dis-
rder, major depressive disorder, obsessive-compulsive disorder, atten-
ion deficit/hyperactivity disorder, linguistic developmental disorders,
ourette syndrome, psychotic disorder), obtaining 280 experiments for
M decreases and 115 experiments for GM increases (Note: this selec-
ion did not require the constraint that increases and decreases be re-
orted in the same study; see Supplementary Fig. S1 for the PRISMA flow
hart and Supplementary Tables S2 and S3 for the lists of experiments
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Table 1 
summary of the pathologies obtained by the first selection of studies. Experiments about psychiatric disorders were included in the meta-analysis, 
while those about neurological disorders were excluded. 
included Diagnosis ICD-10 code Number of experiments for condition 
yes Schizophrenia F20 25 
yes Pervasive developmental disorders, autism F84 13 
yes Bipolar disorder F31 7 
yes Major depressive disorder F31–33 7 
yes Obsessive-compulsive disorder F42 6 
yes Attention deficit/hyperactivity disorder F90 2 
yes Specific developmental disorders of speech and language F80 2 
yes Tourette syndrome F95 1 
yes Other psychotic disorder not due to a substance or known physiological condition F28 1 
no Epilepsy and Recurrent Seizures TLE, JME G40 13 
no Other extrapyramidal and movement disorders G25 4 
no Dystonia G24 2 
no Parkinson’s Disease PD, ET G20 2 
Table 2 
List of experiments obtained by the first selection of studies. Each entry of the list represents an experiment of decrease and one of increase. 
Experiments about psychiatric disorders were included in the meta-analysis, while those about neurological disorders were excluded. 
included author # subjects ICD-10 code Diagnosis 
yes Abell F, 1999 15 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Adler CM, 2005 27 F31 Bipolar Disorder BD, BPD 
yes Antonova E, 2005 40 F20 Schizophrenia SZ 
yes Arnone D, 2009 25 F32-F33 Major Depressive Disorder 
yes Arnone D, 2013 39 F32-F33 Major Depressive Disorder 
yes Bassitt DP, 2007 30 F20 Schizophrenia SZ 
yes Brieber S, 2007 15 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Brieber S, 2007 15 F90 Attention Deficit/Hyperactivity Disorder 
yes Cheng Y, 2011 25 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Cheng Y, 2011 11 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Cheng Y, 2011 12 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Cheng Y, 2011 12 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Cui L, 2011 23 F20 Schizophrenia SZ 
yes Cui L, 2011 24 F31 Bipolar Disorder BD, BPD 
yes Deng MY, 2009 10 F20 Schizophrenia SZ 
yes Deng MY, 2009 10 F20 Schizophrenia SZ 
yes Ecker C, 2010 22 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Ecker C, 2012 89 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Gilbert AR, 2008 20 F42 Obsessive Compulsive Disorder OCD 
yes Giuliani NR, 2005 34 F20 Schizophrenia SZ 
yes Gong Q, 2011 23 F32-F33 Major Depressive Disorder 
yes Gong Q, 2011 23 F32-F33 Major Depressive Disorder 
yes Haldane M, 2008 44 F31 Bipolar Disorder BD, BPD 
yes Ha TH, 2004 35 F20 Schizophrenia SZ 
yes Honea RA, 2008 169 F20 Schizophrenia SZ 
yes Hulshoff Pol HE, 2001 158 F20 Schizophrenia SZ 
yes Hwang J, 2010 26 F32-F33 Major Depressive Disorder 
yes Hyde KL, 2010 13 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Kasparek T, 2010 49 F20 Schizophrenia SZ 
yes Kawasaki Y, 2004 25 F20 Schizophrenia SZ 
yes Ke X, 2008 15 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Ladoucer CD, 2008 20 F31 Bipolar Disorder BD, BPD 
yes Leung KK, 2009 17 F32-F33 Major Depressive Disorder 
yes Lu C, 2010 12 F80 Specific Developmental Disorders of Speech and Language 
yes Ludolph AG, 2006 14 F95 Other Disorders of Psychological Development. Tourette 
yes Marcelis M, 2003 27 F28 Other psychotic disorder not due to a substance or known physiological condition 
yes Mengotti P, 2011 20 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Molina V, 2011 24 F20 Schizophrenia SZ 
yes Molina V, 2011 30 F20 Schizophrenia SZ 
yes O’Daly O, 2007 28 F20 Schizophrenia SZ 
yes Price G, 2010 47 F20 Schizophrenia SZ 
yes Pujol J, 2004 72 F42 Obsessive Compulsive Disorder OCD 
yes Salgado-Pineda P, 2003 13 F20 Schizophrenia SZ 
yes Salmond CH, 2007 9 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Saricicek A, 2015 28 F31 Bipolar Disorder BD, BPD 
yes Scheuerecker J, 2010 13 F32-F33 Major Depressive Disorder 
yes Schiffer B, 2013 25 F20 Schizophrenia SZ 
yes Shapleske J, 2002 31 F20 Schizophrenia SZ 
yes Shapleske J, 2002 32 F20 Schizophrenia SZ 
yes SmesnyS,2010 13 F20 Schizophrenia SZ 
( continued on next page ) 
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Table 2 ( continued ) 
included author # subjects ICD-10 code Diagnosis 
yes Smesny S, 2010 11 F20 Schizophrenia SZ 
yes Suzuki M, 2002 42 F20 Schizophrenia SZ 
yes Szeszko PR, 2008 26 F42 Obsessive Compulsive Disorder OCD 
yes Tang LR, 2014 27 F31 Bipolar Disorder BD, BPD 
yes Toal F, 2010 26 F84 Pervasive Developmental Disorders PDD, autism, ASD 
yes Valente AA Jr, 2005 15 F42 Obsessive Compulsive Disorder OCD 
yes Valente AA Jr, 2005 15 F42 Obsessive Compulsive Disorder OCD 
yes Wang J, 2007 12 F90 Attention Deficit/Hyperactivity Disorder 
yes Watkins KE, 2002 10 F80 Specific Developmental Disorders of Speech and Language 
yes Watson DR, 2012 25 F20 Schizophrenia SZ 
yes Watson DR, 2012 24 F31 Bipolar Disorder BD, BPD 
yes Whitford TJ, 2006 41 F20 Schizophrenia SZ 
yes Wilke M, 2001 48 F20 Schizophrenia SZ 
yes Yoo SY, 2008 47 F42 Obsessive Compulsive Disorder OCD 
no Celle S, 2010 17 G25 Other extrapyramidal and movement disorders 
no Chan CH, 2006 13 G40 Epilepsy and Recurrent Seizures TLE, JME 
no De Araujo-Filho GM, 2009 16 G40 Epilepsy and Recurrent Seizures TLE, JME 
no Etgen T, 2005 28 G25 Other extrapyramidal and movement disorders 
no Granert O, 2011 11 G24 Dystonia 
no Keller SS, 2002 40 G40 Epilepsy and Recurrent Seizures TLE, JME 
no Keller SS, 2002 36 G40 Epilepsy and Recurrent Seizures TLE, JME 
no Keller SS, 2002 58 G40 Epilepsy and Recurrent Seizures TLE, JME 
no Keller SS, 2002 58 G40 Epilepsy and Recurrent Seizures TLE, JME 
no Keller SS, 2002 58 G40 Epilepsy and Recurrent Seizures TLE, JME 
no Kim JH, 2007 25 G40 Epilepsy and Recurrent Seizures TLE, JME 
no Lin CH, 2013 10 G20 Parkinson’s Disease PD, ET 
no Lin CH, 2013 10 G20 Parkinson’s Disease PD, ET 
no Lin CH, 2013 10 G25 Other extrapyramidal and movement disorders 
no Lin CH, 2013 10 G25 Other extrapyramidal and movement disorders 
no Lin K, 2009 30 G40 Epilepsy and Recurrent Seizures TLE, JME 
no Lin K, 2009 19 G40 Epilepsy and Recurrent Seizures TLE, JME 
no Lin K, 2009 30 G40 Epilepsy and Recurrent Seizures TLE, JME 
no Obermann M, 2007 9 G24 Dystonia 
no Riederer F, 2008 12 G40 Epilepsy and Recurrent Seizures TLE, JME 



























































s  ncluded in the control analyses). We will refer to those two control
etwork of decrease-only and increase-only as COA-D and COA-I, re-
pectively. The control datasets do not differ from the two decrease and
ncrease COA-O datasets in term of mean number of subjects (COA-O
ean n. of subjects = 29.8, COA-D mean n. of subjects = 29.5, CAO-I mean
. of subjects = 27.6; decrease COA-O/CAO-D two sample t -test p = 0.87,
ncrease COA-O/COA-I two sample t -test p = 0.53). The mean number
f foci of the decreases COA-O subdataset (6.6) is not significantly dif-
erent from that of the COA-D dataset (mean n. of foci = 9; p = 0.12),
or the mean number of foci of the increases COA-O subdataset (4.8) is
ifferent from that of the COA-I dataset (mean n. of foci = 6.2; p = 0.23).
.2. Quantifying co-alteration probabilities 
Our method is based on the Anatomical Likelihood Estimation (ALE)
 Eickhoff et al., 2009 , 2012 ; Turkeltaub et al., 2012 ). The ALE is a
oordinate-based meta-analytic technique that aims to produce a map
s the union of a set of modelled alteration (MA) maps, each one rep-
esenting one statistical comparison (i.e. experiment) included in the
tudy. For each experiment, its MA map is produced creating a 3-D Gaus-
ian distribution of probability around each reported focus of alteration
 Eickhoff et al., 2009 ). Their union produce a (unthresholded) ALE map,
hich represent the statistical distribution of the alterations across the
xperiments. 
Our aim is to quantify the degree to which a GM change in one brain
egion is associated with a change of opposite polarity in another area.
e do this for all possible pairs of brain regions, thus building a meta-
nalytic COA-O network. To build the network we need a unique set of
odes that can represent both the loci of both decreases and increases,
nd a set of maps that describe the alterations reported by the liter-
ture. To obtain the alteration maps from the foci retrieved from therainMap database, we computed a MA map for each experiment. To
btain the set of nodes, two unthresholded ALE maps were produced
ith GingerALE ( http://www.brainmap.org/ale/ ) for the GM increase
nd GM decrease MA maps of the main dataset. Then, the two maps
ere merged in a single map. When merging, we took the maximum
alue of the two maps for each voxel ( Fig. 1 A), which indicates how
uch a voxel can be considered altered independently of the direction
f changes. This is because we needed a set of nodes that could repre-
ent both increases and decreases. Thus, the merged map represents a
ommon spatial distribution of the GM changes in our database. This
ap was then fed to a peak detection algorithm to identify the coordi-
ates of alteration ( Fig. 1 B). The nodes for the COA-D and COA-I were
btained using the same algorithm on the two separate ALE maps of the
wo control datasets, producing 233 ROIs for the GM-decrease network
nd 269 ROIs for the GM-increase network. Each ROI was used to extract
he meta-analytic signal to calculate the network of co-alterations, so to
ach ROI corresponds a network node. Defining network nodes in this
ata-driven way allows us to more accurately sample the spatial loca-
ions of actual GM changes and, critically, to create equally-sized ROIs.
n fact, each ROI was considered as altered in a given experiment if 20%
f its voxels were included in the corresponding MA map, thresholded
t p < 0.05 ( Fig 1 C). Since the probability indexes used in the analyses
equires binary data of alteration (i.e. a node can be only altered or not,
ee below), this filtering step was necessary to avoid false positive alter-
tions (i.e. labelling a node as altered if it contains only the periphery of
 probability distribution). Although the 20% threshold is arbitrary, it
as been previously shown that other thresholds do not change radically
he results ( Mancuso et al., 2019 ). Using such method, small ROIs are
ore likely to reach such threshold of alteration, thus having equally
ized nodes would avoid such bias. However, to prove that our results
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Fig. 1. Illustration of the methods for the calculation of the decrease-increase association matrix. A : the untresholded ALE maps of the decreases and the increases 
databases are merged. B : such map is fed to a peak detection algorithm to obtain the nodes of the network; C : each node is considered altered in each experiment if 
the 20% of its voxels are covered by a significant MA map voxel of that experiment. This operation produce a vector of 1 and 0 for each node that describes if that 
node is altered or not in each experiment, creating two alteration matrices, one for the decreases, one for the increases. D : the Patel’s 𝜅 is calculated between each 
node vector of the decreases alteration matrix and each node vector of the increases alteration matrix. This produces a matrix of co-alteration between the decreases 
and the increases, which gives us the intensity of the edges of the network. 
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Table 3 
alteration states and marginal probability. 
Node a Node b 
Altered Non-altered 
Altered ϑ1 ϑ3 𝜗 1 + 𝜗 3 
Non-altered ϑ2 ϑ4 𝜗 2 + 𝜗 4 









































































































p  ould hold to different methodological choices, we also replicated the
etwork using a pre-defined parcellation based on the Brainnetome At-
as ( Fan et al., 2016 ). 
This procedure was repeated on each dataset, resulting in 4 node
 experiment matrices of GM changes (i.e., two paired 355 × 64 ma-
rices of decrease-only and increase only for the main analysis, and
wo 233 × 280 and 269 × 115 matrices for the two decrease-only
nd increase-only control networks). The probability of observing a co-
ccurrent change in each pair of nodes was estimated using Patel’s 𝜅
 Patel et al., 2006 ). Table 3 illustrates the possible combinations of two
iven nodes a and b , along with their marginal probabilities. 
Those marginal probabilities are essential for the Patel’s 𝜅, which
alculates the probability that the two nodes show co-occurring GM
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0 , 2 𝜗 1 + 𝜗 2 + 𝜗 3 − 1 
)
 = { 
𝜗 1 − 𝐸 
2 ( 𝑚𝑎𝑥 ( 𝜗 1 ) − 𝐸 ) + 0 . 5 , 𝑖𝑓 𝜗 1 ≥ 𝐸 
0 . 5 − 𝜗 1 − 𝐸 2 ( 𝐸− 𝑚𝑖𝑛 ( 𝜗 1 ) ) , 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒 
The numerator in the fraction is the difference between the likeli-
ood that a and b are altered together and the expected likelihood E
hat a and b are co-altered under independence; E is the prior informa-
ion of our Bayesian framework that, in a frequentist paradigm, would
e disregarded or treated as not fixed by the data ( Patel et al., 2006 ). The
enominator is a weighted normalizing constant to restrict the Patel’s 𝜅
o the range [–1, 1]. The statistical significance ( 𝑝 = 0 . 01 ) is evaluated
hrough a Monte Carlo simulation that calculates an estimate of p ( 𝜅| z )
y sampling a Dirichlet distribution and determining the proportion of
he samples in which 𝜅 > e , where e is the threshold of statistical signif-
cance. The resulting co-alteration matrix (be it COA-O, COA-I, COA-D)
omprises values that are proportional to the statistical relationship be-
ween the alterations of the considered brain areas. 
Crucially, while the co-alteration control matrix was obtained calcu-
ating 𝜅 between the nodes within their respective nodes x experiments
atrices of alteration (233 × 280 for the decrease condition, resulting
n a 233 × 233 COA-D matrix, and 269 x 215 for the increase condition,
esulting in a 269 × 269 COA-I matrix), the COA-O matrix was produced
alculating the 𝜅 between nodes of the decreases matrix and the nodes of
he increases matrix ( Fig. 1 D and S2). It must be stressed that the num-
er of nodes that are effectively connected in the final network is less
han the 355 found with the peak detection algorithm, as some nodes
ave no significant edges after the statistical thresholding. 
For each edge with a significant 𝜅 of the COA-O network, we also
alculated Patel’s 𝜏 ( Patel et al., 2006 ), which evaluates the asymmetriesn conditional probabilities of a given pair of nodes as 
= { 
1 − ( 𝜗 1 + 𝜗 3 ) ( 𝜗 1 + 𝜗 2 ) , 𝑖𝑓 𝜗 2 ≥ 𝜗 3 
( 𝜗 1 + 𝜗 2 ) 
( 𝜗 1 + 𝜗 3 ) − 1 , 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒 
A positive value means that node a is ascendant to (i.e., has an influ-
nce on) node b . In practice, it means that when a shows an alteration, b
sually do not; however, when b is altered, a tend to be altered as well.
herefore, if one of the two nodes is influencing the other, the direction
s more likely to go from a to b than the other way around. This concept
ight be easier to understand considering that the 𝜏 is calculated tak-
ng into account the ratio between the probability of a and b ( ϑ1 + ϑ3 and
1 + ϑ2 respectively, regarded as priors in the Bayesian framework), thus
ndicating if it is more likely to have an alteration in a or in b , given
heir reciprocal dependence. Therefore, the identity of node a and b is
rucial to understand the results of the calculations. In our implemen-
ation ( Fig. 1 D), the co-alteration is calculated taking a decrease node
s node a and an increase node as node b (see online Video 1). As a
esult, a positive value means a possible influence of a GM decrease on
n increase. Obviously, the choice of computing the co-alterations from
he decrease nodes to the increase nodes was arbitrary, but doing the
pposite would have not changed the results in a meaningful way. 
.3. Resting state functional connectivity 
Functional data were retrieved from the Cambridge dataset of the
unctional Connectome Project ( Biswal et al., 2010 ). The sample com-
rises 198 subjects (75M-123F, 18–30 years old). Each scan consists of
19 time points with TR = 3. These data were processed with DPABI 3.1,
PARSFa 4.4 ( http://rfmri.org/DPARSF ) ( Yan et al., 2016 ). The pre-
rocessing steps were i) slice timing correction; ii) realignment; iii) re-
ression of motion parameters using the Friston-24 model and of white
atter and cerebrospinal fluid signals using a priori masks; iv) spatial
ormalization to standard SPM EPI template; v) smoothing with a 4 mm
WHM kernel; vi) scrubbing as in Power et al. (2012) . 
Then we extracted the functional signal of the 355 ROIs of the COA-
 network to calculate the individual matrix of time series correlations,
hich were then normalized with the Fisher transformation and aver-
ged into a group FC matrix. 
To further investigate the relationship between the COA-O network
nd normative FC, each node was assigned to a resting state network
RSN) of the Yeo7 parcellation ( Yeo et al., 2011 ), plus the cerebellum
nd a thalamus/basal ganglia masks (Thal/BG) created on the basis of
he Brainnettome Atlas. 
.4. Fail-safe and dummy-pairs analyses 
We might hypothesize that the dataset of the experiments included
n the COA-O analysis could be just a subsample of all the possible
vidences about GM changes of opposite polarity, thus biasing our
esults. To assess their robustness, we implemented a modified ver-
ion of the Fail-safe technique ( Acar et al., 2018 ). The ratio behind
hat is that we cannot represent the COA-O network as if we gath-
red all the possible experiments on the matter, but we still can ob-
erve what would happen if our sample was much larger. Therefore,
e generated 220 couples of random MAs using the fail-safe R script
 https://github.com/NeuroStat/GenerateNull ). Such MAs couples were
rogressively introduced in the database 10 at a time, recalculating the
etwork after each injection. Then, the values of the edges of each new
etwork were correlated with those of the original COA-O network.
ince it is possible that any injection step could improve the correlation
y mere chance, the method can produce random fluctuations in the
orrelation values, so the procedure was repeated 30 times. The more
he network would hold to the injection of noise, the more it could be
ssumed that our network is an accurate representation of the COA-O
henomenon, even if our dataset was a subsample of a much larger set






























































































































i  f experiments. The Fail-safe test has also the purpose of overcome the
le-drawer effect ( Acar et al., 2018 ), that is, to ensure that the results
ere not affected by some bias of the literature or of the sample of stud-
es included in the database. Thus, this analysis has also a more broad
im to validate the generalizability of the results. 
To calculate the co-alteration matrix, it was necessary to couple an
xperiment of decreases to the matching experiment of increases ob-
ained on the same subjects. This forced us to discard all the papers that
o not present the opposing statistical contrast between patients and
ealthy controls group. In general, this meant that we discarded many
tudies that only reported GM decreases in patients and provided no in-
ormation about GM increases. There are two possible explanations as to
hy a study might only report GM decreases. One is that the researchers
ever tested for GM increases, despite the fact that they actually exist in
he patient group. In this case, the data are incomplete and so it is nec-
ssary to discard these studies. The second reason is that the researchers
an the contrast and found no evidence of GM increases. In this case, the
ata are informative and should be included in the analysis. However,
here is no way to disambiguate case 1 from case 2, so all non-matched
xperiments had to be excluded. To evaluate how much this decision
mpacted on the results, we progressively injected the database with de-
rease experiments randomly sampled from the control dataset (see Data
ollection). Each one of these experiments was matched with a dummy
ncrease experiment with no foci. We added 10 of these dummy pairs
f experiments to the main database at each time, until we injected 220
ummy pairs, and repeated this procedure 30 times. The same analysis
as made with increases. If the results hold to a consistent injection of
ummy-pairs in the database, we could conclude that our network do
ot suffered the decision to exclude the unmatched experiments. 
. Results 
Our first selection of studies produced 85 decrease and 85 increase
xperiments coupled to each other. Table 1 contains the number of ex-
eriments for each of the disorders of such dataset. The distribution
f psychiatric and neurological pathologies in those experiments was
symmetrical, with 64 experiments related to 9 psychiatric diagnoses
nd 21 experiments to 4 neurological ones. Of the latter, 13 were re-
ated to epilepsy, the remaining to extrapyramidal and movement dis-
rders ( 𝑛 = 4 ), Parkinson’s disease ( 𝑛 = 2 ) and dystonia ( 𝑛 = 2 ). Thus, it
eems that the coupling of decreases and increases is more characteristic
f psychiatric conditions than neurological ones (with the only excep-
ion of the epilepsy), therefore, we decided to focus our analysis only
n psychiatric disorders. The COA-O network comprising neurological
isorders can be seen at Supplementary Fig. S3. 
.1. Decrease-increase association network 
The COA-O network for psychiatric diseases is presented in Fig. 2
nd online Video 2. Although our network-mapping procedure produced
55 nodes, only 97 of them (32%) showed statistically significant co-
ccurrent changes with another region. For this subset of 97 nodes, we
dentified 292 significant co-occurrence probabilities, which represent
dges in the COA-O network. Each edge in this network connects two
reas showing GM changes in opposing directions. Of the 97 nodes in the
etwork, 46 showed a GM decrease, 38 showed a GM increase, and 13
howed both (a node can assume both the roles of decrease and increase
n different edges). 
GM increases and decreases are not uniformly distributed through-
ut the network. For instance, the superior parietal lobule (SPL) has
 high concentration of areas with increased GM (0 nodes showing a
ecrease and 6 showing an increase), while the left insula and left infe-
ior frontal gyrus (IFG) contain many nodes of decreased GM (10 decre-
ase nodes, 1 increase node, 3 nodes are both decrease and increase),
s showed by their nodal strength. The strengths (i.e. weighted degree
entrality) of decreases and increases were calculated as the sum of eachow and each column of the COA-O matrix, respectively. Node strength
s unevenly distributed between hemispheres, with the left hemisphere
aving higher strength nodes than the right ( Fig. 2 B). In fact, of the
5 nodes with highest strength, only 5 were in the right hemisphere
 Table 4 ). Involvement of regions in the occipital lobe and posterior
emporal lobes, and anterior prefrontal cortex, in the network is sparse.
ost of the nodes, especially the ones with high strength, are situated in
he anterior temporal and inferior frontal cortices, thalamus, and basal
anglia. 
These findings were replicated using the Brainnetome atlas, produc-
ng a similar network and thus demonstrating that our method is inde-
endent of the node definition procedure (Supplementary Fig. S4). The
etwork build excluding the 5 experiments whose patient group was a
ubgroup or was partly overlapping with another one correlates r = 0.79
ith that calculated over the whole database ( p < 0.01), and it is shown
n Fig. S5. 
.2. Relationship between co-occurrent changes and functional connectivity
Considering that COA-D and COA-I networks were previously found
o be significantly correlated with normative connectivity, we expected
hat it could be the same for the COA-O network. Contrary to our hy-
othesis, the 292 significant Patel’s 𝜅 values of the COA-O matrix were
ot correlated with the 292 corresponding Pearson’s r values of the FC
atrix ( r = − 0.07, non-significant at p = 0.05). If COA-O edges were cor-
elated to FC, it could be expected that most of them connected nodes
elonging to a same canonical resting state networks (RSN), within
hich FC values tend to be high. Given the lack of correlation between
ur COA-O edges and normative FC, we hypothesised that the edges
f the COA-O network tend to connect nodes belonging to different
SNs. Thus, each node was assigned to one of the RSN of the Yeo7
arcellation ( Yeo et al., 2011 ), plus the cerebellum and the Thal/BG.
f the 292 edges, only 49 are between nodes of the same RSN, whereas
3% link nodes that belong to different RSNs. In comparison, COA-I
nd COA-D networks have a lower fraction of between-RSNs edges. The
etween-RSN edges of the COA-D network represent 78% of the total;
he fraction is 68% for the COA-I. To evaluate the statistical significance
f these differences, we randomized the COA-O, COA-D and COA-I net-
orks using the Maslov-Sneppen algorithm ( Maslov and Sneppen, 2002 ;
ubinov and Sporns, 2010 ) to preserve the degree distribution of each
etwork. We then computed the differences in between-RSN edge frac-
ions between the randomized networks and repeated the process 1000
imes to build an empirical null distribution. The observed between-
SN fractions were significantly higher for the difference between the
OA-O network and COA-D network ( p < 0.001) and between the COA-
 network and COA-I network ( p < 0.001). Thus, although in compar-
son with the COA-D network the difference is only of 5% (13% with
he COA-I network), co-occurrent GM changes of opposing polarity are
ignificantly more likely the occur between brain regions belonging to
ifferent functional networks. 
Focusing on the COA-O network, many between RSN edges are inci-
ent upon DMN nodes ( Fig. 3 ). Most nodes mapped to the DMN show
ecreased GM, thus the areas to which these nodes connect in the
OA-O network almost always show increased GM (especially Thal/BG,
alience and Executive control networks). The DMN is also the RSN with
ore nodes in the COA-D network, but it is poorly represented in the
OA-I network, further supporting a higher frequency of GM reductions
n this brain network. Almost all COA-O edges within the DMN con-
ect to a single node showing increased GM located in the ventromedial
refrontal cortex ({x,y,z} = [ − 16, 34, − 4]). This indicates that it is rel-
tively rare to find co-occurring GM increases and decreases within the
MN. 
As with the DMN, the ECN and, overall, the SN mostly comprise
odes showing GM decreases. In contrast, the dorsal attention network
DAN) is comprised almost only of nodes showing GM increases, located
n the SPL ( Fig. 2 ), and mostly associated with decreases in the Thal/BG
L. Mancuso, A. Fornito and T. Costa et al. NeuroImage 222 (2020) 117220 
Fig. 2. A : network of co-alterations of opposite GM changes, showing the unconnected nodes in grey colour. B : network of co-alterations of opposite GM changes. 
C : nodal strength of the network. The size of the nodes is proportional to the weighted degree centrality. 
L. Mancuso, A. Fornito and T. Costa et al. NeuroImage 222 (2020) 117220 
Table 4 
The 25 nodes with the highest strength. 
Node x y z Type of alteration Strength 
Left Anterior Insula (BA 13) − 42 16 0 decrease 8.33 
Left Thalamus − 2 − 18 6 decrease 7.74 
Left Inferior Frontal Gyrus (BA 47) − 40 26 − 6 decrease 7.35 
Left Parahippocampal gyrus (BA 35) − 26 − 20 − 20 both decrease and increase 7.2 
Left Inferior Frontal Gyrus (BA 47) − 36 16 − 8 decrease 6.89 
Left Putamen − 22 0 12 increase 6.47 
Left Parahippocampal gyrus (BA 28) − 14 − 16 − 20 both decrease and increase 6.36 
Left Amygdala − 18 − 8 − 14 both decrease and increase 6.27 
Left Paracentral Lobule (BA 5) − 4 − 42 50 increase 5.94 
Left Thalamus − 8 − 22 − 2 decrease 5.63 
Left Parahippocampal gyrus (BA 36) − 32 − 12 − 20 both decrease and increase 5.59 
Left Putamen − 28 − 8 12 increase 5.36 
Left Thalamus − 10 − 10 0 both decrease and increase 5.23 
Left Anterior Insula (BA 13) − 40 2 12 both decrease and increase 5.23 
Right Putamen 22 2 2 both decrease and increase 5.18 
Left Caudate Body − 10 10 12 both decrease and increase 5.17 
Left Anterior Cingulate Gyrus (BA 32) − 16 34 24 decrease 5.03 
Left Putamen − 22 8 6 increase 5.01 
Left Medial Frontal Gyrus (BA 9) − 6 40 24 decrease 4.85 
Right Inferior Parietal Lobule (BA 40) 40 − 56 38 decrease 4.83 
Left Anterior Cingulate Gyrus (BA 32) − 12 36 14 decrease 4.83 
Left Inferior Frontal Gyrus (BA 47) − 32 26 0 both decrease and increase 4.82 
Right Postcentral Gyrus (BA 5) 10 − 42 66 increase 4.57 
Right Paracentral Lobule (BA 5) 4 − 44 56 increase 4.34 
Left Inferior Frontal Gyrus (BA 47) − 28 22 − 10 both decrease and increase 4.29 
Fig. 3. A : network of co-alterations of opposite GM changes, showing the unconnected nodes in grey colour. B: network of co-alterations of GM decreases, showing 
the unconnected nodes in grey colour. C: network of co-alterations of GM increases, showing the unconnected nodes in grey colour. 






























































































































T  nd IFG ( Figs. 2 , 3 and Supplementary Table S4). The cerebellum has
nly two increase nodes associated to the DMN and the ECN and that
ere not replicated using the Brainnetome atlas. In general, most edges
f the COA-O are focused on regions in the telencephalon. A table listing
ll edges can be found in the Supplementary Materials (Table S4). 
The node distribution across RSN is non-random. The DMN and
hal/BG are the RSNs with more nodes, while the cerebellum and visual
etwork are the less represented. To evaluate if this spatial distribution
s statistically significant, we randomly picked 97 nodes from a homoge-
eous parcellation ( Fornito et al., 2010 ; Zalesky et al., 2010 ). A permu-
ation test showed that, apart from the DMN, all the RSNs have a number
f nodes significantly different from the null model ( p = 0.05, one-tailed
 -test, 10,000 permutations). RSNs with few nodes have less nodes than
xpected from chance (Visual, p < 0.001; Sensorimotor, p = 0.0398; DAN,
 = 0.0119; Cerebellum, p < 0.001), while the bigger ones have signifi-
antly more nodes (Salience, p = 0.0105; Limbic, p = 0.0326, Executive
ontrol, p = 0.0381; Thal/bg, p < 0.001). 
It is interesting to notice that the COA-D and COA-I have an higher
roportion of connected nodes than the COA-O network. In fact, while
nly the 32% of the nodes were found to be connected in the COA-O
etwork, the COA-D network had 230 connected nodes on 233 (99%),
nd the COA-I network had 135 connected nodes on 269 (50%). This
ndicates that, whatever the explanation for the COA-O phenomenon, it
eems to occur less frequently than the co-alterations of same sign. An
nalytic comparison of the brain regions that appear to be connected or
ot connected in the three forms of co-alteration is behind the scope of
his paper. However, as can be observed in Fig. 4 , there is only a COA-D
ode in the superior parietal cortices, and it is unconnected, while the
OA-I network displays several connected nodes in such region. Inter-
stingly, this region is characterized by increase nodes in the COA-O
etwork. Also, the COA-I network shows unconnected nodes in the su-
erior medial frontal cortex, where some decrease nodes can be found
n the COA-O network. It is important to specify that such form of be-
aviour is not necessarily to be expected, as many other regions present
onnected nodes in all the three networks. Therefore, it seems that the
uperior parietal lobe is specific to GM increases that are associated to
oth other increases and decreases, while the areas along the midline of
he superior frontal cortex tend to be more specific to decreases showing
imilar behaviour. 
.3. Fail-safe and dummy-pairs analyses 
As our COA-O dataset of experiments is relatively small, we assessed
he robustness of our results to the injection of noise with a modified
ail-safe technique ( Acar et al., 2018 ). We observed that the COA-O
etwork is still correlated (r ≈ 0.3) with the original one even after
e added 220 null maps (~350% of the original dataset, Fig. 3 C). This
eans that, if our dataset was much larger, the network might remain
elatively stable, unless the injection of real data was somehow much
ore harmful to the results than that of null studies. 
To verify that our results were not severely affected by the neces-
ity of including only the couple of experiments showing opposing GM
hanges, we added a set of uncoupled experiments, paired with an empty
ne. The results can be seen at Fig. 3 D and E. The network resulting from
he addition of 220 decrease experiments paired with empty ones corre-
ates with the original one at r = 0.88 (averaged across 30 runs). Apply-
ng the same procedure adding only GM increase experiments produced
 network that correlated with the original one, on average, r = 0.79.
hus, our results would if we did not exclude non-matching experiments.
.4. Directionality of the decrease-increase associations 
We further assessed the directionality of the edges of the COA-O net-
ork using the Patel’s 𝜏, which compares the conditional probabilities
f having an alteration of region a given a change in b and of a change
n b given a change in a . A positive edge means that it is more probableo have an increase given a decrease than the other way round, while a
egative edge means that it is more probable to have an increase given a
ecrease. The 𝜏 network is characterized by both positive and negative
dges ( Fig. 5 ) although positive edges are slightly stronger and more
umerous. Many negative edges are incident upon nodes of the parietal
obe that are characterized by GM increases. Conversely, the nodes in
he left IFG and the thalamus, which represent areas of GM decrease, are
onnected by many positive edges ( Fig 5 and S6). Many positive edges
ink a decrease of the salience network or the DMN to a decrease in the
hal/BG, but also DMN to SN and SN to limbic network. Negative edges
re more distributed across RSNs ( Fig 5 ). In general, these findings in-
icate that the edges of the COA-O network are often directed from the
ecrease nodes to the increase nodes, but also the opposite can be true.
. Discussion 
Our meta-analytic research investigated the possible relationship be-
ween GM increases and decreases across neurological and psychiatric
isorders. However, a first assessment of the BrainMap database indi-
ated that co-occurrent decreases and increases in GM volume are rarely
eported in neurological diseases, with epilepsy being an exception. Con-
ersely, such co-occurrent changes where more commonly found in psy-
hiatric disorders. This result might reflect a reporting bias in the neu-
ology literature to focus only on GM decreases. However, it may also
epresent a genuine increase in the likelihood of observing GM increases
n psychiatric disorders and epilepsy. In fact, a common thread link-
ng these two is that many of them have a neurodevelopmental origin,
hich may provide greater opportunity for plastic adaptations and thus
he emergence of GM increases. 
In psychiatric disorders, our analysis revealed that GM increases and
ecreases are not independent; instead, many areas show a GM change
hat is statistically related to a change of opposite polarity in other ar-
as. This is consistent with the findings by Guo et al. (2016) about the
egative covariance in schizophrenia subjects’ cortical thickness. Our
esearch extended their results to a wider spectrum of psychiatric dis-
ases. Also, it utilized a meta-analytical technique, based on a robust
ayesian statistics, that deals with the notion of pathological alteration
ather than with anatomical variance. Given the difference between the
wo methods, it is meaningful that they both indicated the existence of
ome form of relation between GM changes of opposite sign. 
The COA-O network obtained with our technique presents a series of
nteresting features. For instance, there appears to be a preponderance of
eft hemisphere nodes being more strongly involved in such coordinated
M changes ( Fig. 2 ). The left hemisphere dominance in the COA-O net-
ork is intriguing and might suggest a differential involvement of the
wo hemispheres in the anatomy of psychiatric disorders. It has recently
bserved ( Cauda et al., 2020 ) that, while the hubs of COA-D are more
oncentrated in a set of areas of the left hemisphere, those of COA-I
irror the same areas of the left one. This finding, along with the cur-
ent results about the stronger COA-O hubness of the left hemisphere,
uggest that might be an effect of lateralization or an interhemispheric
nterplay that is involved in the relationship between decreases and in-
reases co-alterations. 
The nodes involved in the COA-O phenomenon are not randomly
istributed across the networks. In particular, the SN and ECN showed
ore nodes than expected by chance, consistent with their pre-
umed importance in psychiatric pathology ( Goodkind et al., 2015 ;
cTeague et al., 2017 , 2016 ; Palaniyappan and Liddle, 2012 ; Sha et al.,
019 ; Sheffield et al., 2017 ). The thalamus and basal ganglia also
howed more significant nodes than expected by whereas the DMN does
ot. In fact, most canonical RSNs contained significantly fewer COA-O
odes than expected by chance. Notably, while the Thal/BG showed an
pproximately equal number of decrease and increase nodes, the DMN
s mostly characterized by decreases. Such decreases were often found
o be associated to Thal/BG increases, and increases in the SN and ECN.
he ECN and, to a lesser extent, the SN, show a similar propensity for
L. Mancuso, A. Fornito and T. Costa et al. NeuroImage 222 (2020) 117220 
Fig. 4. A and B : co-alteration networks represented in 2D, dividing each node for one of the Yeo7 RSN, plus cerebellum and thalamus/basal ganglia. The size of the 
nodes is proportional to the degree centrality, standardized across networks. DAN: dorsal attention network; DMN: default mode network; ECN: executive control 
network; Vis: visual network; S/VAN: salience/ventral attention network; Thal/BG: thalamus and basal ganglia, comprising upper midbrain. A : decrease-increase 
co-alteration network. The transparency of the edge is inversely proportional to its 𝜅 value. Note that the arrows do not mean that the network is directed in a strict 
sense as the Patel’s 𝜅 is not a measure that provide a directionality. However, each edge links two nodes of different modality: one is a decrease and the other is 
an increase. Arrows were used to indicate at which side of the edge is the increase node. B : decrease only and increase only co-alteration networks. C : plot of the 
30 runs of the Fail-safe analysis. On the x-axis: level of the null model. For each level, 10 random modelled alteration maps were added to the database. On the 
y-axis: values of Pearson’s r between the original decrease-increase association network and each of the level of the model. D : plot of the 30 runs of the dummy-pairs 
analysis with control decreases plus dummy increases. E : plot of the 30 runs of the dummy-pairs analysis with control increases plus dummy decreases. 
L. Mancuso, A. Fornito and T. Costa et al. NeuroImage 222 (2020) 117220 
Fig. 5. A : directed network of decrease-increase co-alteration. Positive edges indicates that the decrease node is dominant on, and possibly influences, the increase 
node. Negative edges indicates the opposite. B : hubs of the directed network, divided for positive hubs (left) and negative hubs (right). Note that these images 
were produced calculating the strength of each node on the whole Patel’s 𝜏 matrix, and then separated between the nodes with a positive value and those with a 
negative value. Thus, the strength of each node represents its balance between the positive and negative edges incident upon it. Therefore the size of the node is 
not proportional to the number of its edges, since positive and negative edges incident upon a same node cancel each other. See Supplementary Figure S6 for a 
representation of the strength of positive-only and negative-only edges. C : 2D representation of the directed network. Positive edges indicates that the decrease node 
is dominant on, and possibly influences, the increase node. Negative edges indicates the opposite. DAN: dorsal attention network; DMN: default mode network; ECN: 
executive control network; Vis: visual network; S/VAN: salience/ventral attention network; Thal/BG: thalamus and basal ganglia, comprising upper midbrain. 































































































































ecrease nodes associated with Thal/BG increases, indicating that GM
ecreases in the three higher order cortical networks are often accom-
anied by GM increases in subcortical structures. 
Another relevant aspect of the COA-O network was the tendency of
ts edges to connect different RSNs. In fact, analysing the COA-O net-
ork for psychiatric disorders, we observed that it is not correlated to
C, and that its edges tend to connect different RSNs. Prior work has
hown a closer association between FC and co-occurrent GM decreases
r increases, which can be largely explained by models of diffusion along
onnectivity pathways ( Cauda et al., 2018b ; Raj and Powell, 2018 ). Our
ndings thus suggest that co-occurent GM changes of opposing polar-
ty may emerge through a distinct phenomenon. Candidate mechanisms
nclude effects of medication, direct effects of disease, or compensatory
r maladaptive responses to insult. 
.1. GM increases due to medication 
It is possible that increased GM in psychiatric disorders is not due
o the disease process, but instead reflects a secondary consequence
f medication. For instance, it has been reported that lithium, com-
only used to treat bipolar disorder, has a neurotrophic and morphome-
ric increase effect ( Angelucci et al., 2003 ; Bearden et al., 2008 , 2007 ;
eyer et al., 2004 ; Chen et al., 2000 ; Frey et al., 2006 ; Fukumoto et al.,
001 ; Hajek et al., 2012 ; Hammonds and Shim, 2009 ; Hashimoto et al.,
003 ; Hibar et al., 2018 ; Kempton et al., 2008 ; López-Jaramillo et al.,
017 ; Lyoo et al., 2010 ; Manji et al., 1999 , 1997 ; Monkul et al., 2007 ;
oore et al., 2000 ; Sassi et al., 2002 ; Yucel et al., 2008 , 2007 ). Simi-
arly, the use of conventional antipsychotics has repeatedly been associ-
ted with basal ganglia ( Chakos et al., 1998 , 1994 ; Chopra et al., 2020 ;
eshavan et al., 1994b ; Kippin et al., 2005 ; Muller and Seeman, 1977 ;
urali et al., 1995 ; Sedvall et al., 1995 ; Shihabuddin et al., 1998 ) and
halamic ( Dazzan et al., 2005 ; Gur et al., 1998 ; Strungas et al., 2003 )
natomical increases. 
Given that many patients included in our meta-analysis were under-
oing medication at the time of the scan (Table S5), this variable is likely
o have some impact on the COA-O network. However, there is some
vidence that suggests that medication alone is unable to explain our
esults: first, morphological effects of medication are often found to be
ocalized to restricted regions, such as medial temporal lobe and subgen-
al cortex with lithium ( Germaná et al., 2010 ; Hafeman et al., 2012 ) and
G with antipsychotics ( Navari and Dazzan, 2009 ), while our increase
odes are situated in many other brain areas; second, some studies re-
ort that medications could attenuate pathological decreases rather than
ncrease GM volume in patients compared to controls ( Hibar et al., 2016 ;
arrazin et al., 2019 ; Sheline et al., 2003 ; Wada et al., 2005 ; Zung et al.,
016 ); third, atypical antipsychotics, although found by some to be
eurotrophic and induce neurogenesis ( Bai et al., 2003 ; Halim et al.,
004 ; Park et al., 2006 ; Wakade et al., 2002 ; Wang et al., 2004 ) pro-
uced mixed volumetric findings ( Massana et al., 2005 ; Navari and
azzan, 2009 ) but often no increase effects were found in the BG
 Chakos et al., 1995 ; Frazier et al., 1996 ; Lang et al., 2004 , 2001 ;
cheepers et al., 2001 ; Westmoreland Corson et al., 1999 ). Moreover,
 study reports an absence of increased volume of BG also for typical
ntipsychotics ( Kreczmanski et al., 2007 ); fourth, anticonvulsant drugs,
sed in the treatment of bipolar disorder but also for epilepsy (the only
eurological disease with a non-negligible number of experiments in our
atabase) showed to produce decreases or no effect ( Abé et al., 2016 ;
hang et al., 2009 ; Germaná et al., 2010 ; Hibar et al., 2018 ); fifth, the in-
reased striatal volume of relatives of schizophrenic patients suggests a
enetic factor ( Oertel-Knöchel et al., 2012 ). Similarly, increased cortical
hickness and subcortical volume were found also in drug-naive patients
ith depression ( Li et al., 2019 ; Qiu et al., 2014 ; Reynolds et al., 2014 ;
uh et al., 2019 ; Yang et al., 2015 ; Zuo et al., 2018 ); sixth, patients
ith autism or development disorders included in our study were not
nder drug treatment (Table S5); seventh, if GM increases were purely
xplained by medication, they would most likely be statistically asso-iated to all, or most of, the GM decreases. On the contrary, the nodes
f increase were selectively co-altered with one or few decreases. The
ffect of medication thus cannot provide the sole explanation for the
bserved findings in the COA-O network. 
.2. Co-occurrent increases and decreases as a direct effect of the pathology
One possible hypothesis might be that GM increases are as di-
ect effect of the disease process. Co-occurring GM decreases and in-
reases could arise due to regionally distinct effects of inflammatory
rocesses ( Li et al., 2019 ), or, possibly, altered developmental prun-
ng ( Frith, 2004 ; Keshavan et al., 1994a ; Kim et al., 2017 ; Tang et al.,
014 ). Considering the importance of pruning in the development
f the healthy brain and in the building of a normal connectome
 Khundrakpam et al., 2013 ; Menon, 2013 ; Neniskyte and Gross, 2017 ;
upekar et al., 2009 ), it could be speculated that abnormal hyper- and
ypopruning mechanisms might be responsible of the coupled decreases
nd increases observed in the present study in neurodevelopmental dis-
rders. 
Another option could be that, due to dysregulation of ascending
euromodulatory projection systems ( Davis et al., 1991 ; Sesack and
arr, 2002 ), different areas of the brain may become hyperactivated
r hypoactivated, potentially resulting in coordinated and concomitant
ncreases and decreases in volume through activity-dependant plastic-
ty. These changes could be driven by neurodevelopmental miswiring of
onnectivity, resulting in a de-differentiation of function ( Fornito et al.,
015 ). 
.3. Co-occurrent increases and decreases as a form of compensation 
Another hypothesis might be that GM increases reflect a compen-
atory response to decreases. In fact, it has been reported that the
rain topology of chronic patients shows modifications that appears to
ounter or normalize those occurred as consequence of a pathologic per-
urbation ( Hillary et al., 2015 ; Lord et al., 2012 ; Palaniyappan, 2017 ;
alaniyappan et al., 2019 ). The seemingly most logical consequence of
his view should be that the COA-O would happen between regions
ith similar function and thus belonging to the same RSN. Indeed, it
as previously shown that, in schizophrenic patients, over- and under-
ctivations are often located in topologically close areas ( Crossley et al.,
016 ). Our data are not consistent with this scenario, as COA-O edges
re not correlated with FC and are more often between- than within-RSN
 Fig. 2 ). Given prior reports that strongly connected areas tend to share
M changes in the same direction ( Cauda et al., 2018b ; Shafiei et al.,
020 ), our findings suggest that such regions may have a limited ca-
acity for compensation, possibly due to diaschisis and other maladap-
ive responses ( Carrera and Tononi, 2014 ; Fornito et al., 2015 ). There-
ore, a region which is not strongly connected to a damaged area but
as a related function may be the best candidate to take on a compen-
atory role. For instance, the SPL nodes of increases are especially asso-
iated with decreases in the insula/IFG and Thal/BG. Despite belonging
o distinct RSNs, these areas have all been implicated in pain percep-
ion ( Bräscher et al., 2016 ; Chudler and Dong, 1995 ; Fitzek et al., 2004 ;
reund et al., 2009 ; Kong et al., 2006 ; Lu et al., 2004 ; Schoedel et al.,
008 ; Strigo et al., 2003 ; Tseng et al., 2010 ), somatosensory per-
eption in general ( Nagy et al., 2006 ; Olausson et al., 2005 , 2002 ;
obbe, 2018 ; Stoeckel et al., 2004 ; Yoo et al., 2003 ), and motor func-
ions ( Beurze et al., 2007 ; Binkofski et al., 1999 ; Groenewegen, 2003 ;
errero et al., 2002 ; Jovicich et al., 2001 ; Kertzman et al., 1997 ;
angner et al., 2014 ; Lotze et al., 2006 ; Naito et al., 2008 ; Stephan et al.,
995 ), although the SPL can also be associated to top-down attention as
art of the DAN ( Corbetta and Shulman, 2002 ; Yeo et al., 2011 ). 
The concept of compensation usually involves an adaptive change for
he individual, however some have suggested that neuroplastic modifi-
ations consequential to psychiatric diseases might also be dysfunctional
or the patient well-being ( Amad et al., 2019 ; Palaniyappan, 2019 ). 



















































































































.4. Directionality of the associations 
Using Patel’s 𝜏, we also produced a directed network of COA-O, rep-
esenting the ascendancy (influence) of decreases to increases. The re-
ulting network shows a clear separation of positive and negative edges,
ith the former being more prevalent between fronto-temporal nodes
nd the latter being incident upon parietal nodes ( Fig. 5 ). Theoretically,
his could be interpreted as an influence of the parietal increases on
he frontal and gangliar decreases, while in the rest of the brain the di-
ectionality tend to go from decreases to increases. Although this is an
nteresting observation that suggests that the COA-O mechanisms might
ork differently in distinct parts of the brain, there are several possi-
le explanations for this observation. Critically, while the unbalance of
onditional probabilities might indicate an influence of a node on the
ther, it could also result from the action of a third agent. In fact, if
ode a and b are both influenced by an element external to the couple,
ut one of the two nodes is more vulnerable to its action than the other,
e would obtain the same unbalanced probabilities of alteration. Such
 third agent could be another node or the pathology itself, to which the
wo regions would be differently vulnerable. Such differential vulnera-
ility expresses in two ways: one of the nodes undergo a GM decrease
hile the other an increase, and one of the two node is more likely to
e modified than the other. Therefore, the ascendancy as we calculated
t could be either interpreted as a measure of influence of a node on the
ther, or as an evidence of a sort of primacy of a node over the other in
he system of COA-O. In fact, considering that the COA-O edges do not
orrespond to those of FC, the hypothesis of a direct influence of a node
n another seems the less likely of the two. 
.5. Limitations and future directions 
The main limitation of this study comes from a relatively small sam-
le of included experiments. Although we adopted a transdiagnostic ap-
roach, only 64 comparisons reported both increases and decreases on
sychiatric patients in the BrainMap database. We suspect increases can
e sometimes overlooked and not reported by some authors, producing
 file-drawer effect. However, our Fail-safe technique showed that our
etwork remains relatively preserved also after the injection of ~350%
f noise, reassuring us about the validity of our results. Moreover, even
f we include non-coupled experiments, the network remains remark-
bly similar, indicating that the COA-O edges can be attenuated, but
ot radically changed if including papers that do not presented both
M changes in the database. 
The BrainMap database is only a subsample of the VBM literature.
lthough there is no reason to suspect any systematic bias in the selec-
ion of the papers coded in the database, it could be legit to question
he generalizability of our results, for instance because a file-drawer ef-
ect. However, the Fail-safe technique has also and especially the role
o overcome this issue ( Acar et al., 2018 ). The high resistance of our re-
ults to the test might indirectly advocate for their representativeness.
n the other hand, when removing 5 experiments having an overlapping
ample of patients with others, the resulting network is overall similar,
owever the change was non-negligible. This particularly advocates for
urther replications with larger datasets and different methodologies. 
The transdiagnostic approach embraced here was motivated by the
nterest in general brain mechanisms of COA-O, but disease-specific in-
estigations would be of great interest as well. The scarcity of experi-
ents retrieved by our search prevented us to do so, but future meta-
nalyses might be able to gather more data. 
Longitudinal or cross-sectional studies are also needed to ascertain
he presence of COA-O in individual’s brains, and the temporal trajecto-
ies that could suggest a directionality between decreases and increases.
lso, it could be important to evaluate the developmental phases in
hich increases and decreases begin to display some form of associa-
ion. For instance, as both hyper- and hypopruning were hypothesized
o take place in autism ( Thomas et al., 2016 ), it might be possible thatOA-O emerges concurrently with pruning or myelination developmen-
al phases. Moreover, functional neuroimaging and clinical assessment
ould be critical to evaluate the eventual compensatory function of the
OA-O phenomenon. 
The use of the Patel’s 𝜏 has been advocated by some as a valid method
o investigate network directionality ( Smith et al., 2011 ), but the suit-
bility of its use in the calculation of effective connectivity has also been
everely questioned by others ( Wang et al., 2017 ). However, our study
as not utilised the Patel’s 𝜏 in search of a strict causal directionality, but
o investigate a more general notion of directionality between nodes. 
.6. Conclusions 
Our analysis provides evidence for coordinated GM decreases and
ncreases in psychiatric disorders, with such coordinated changes prin-
ipally affecting higher-order association networks and subcortical re-
ions. Our findings open a new line of research into the mechanisms
nderlying coordinated GM changes of opposing polarity, which could
otentially shed some light on the intricate symptomatology and recov-
ry dynamics in psychiatric and neurodevelopmental diseases. 
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